BERKELEY, Calif. and MAINZ, Germany - Mainz Biomed NV (NASDAQ:MYNZ), a company focused on early cancer detection diagnostics, has announced its return to compliance with Nasdaq's stockholders' equity ...

After an underwhelming 2023/24 season, Mainz are now in the running for the UEFA Champions League places. So what's clicking ...

German-born U.S. midfielder Lennard Maloney has joined Mainz from Bundesliga rival Heidenheim where he was dropped last month ...

Sky Germany reports that Mainz are now leading the race ahead of Borussia Mönchengladbach for Montpellier forward Arnaud ...

Please visit Mainz Biomed’s official website for investors at mainzbiomed.com/investors/ for more information About Mainz Biomed NV Mainz Biomed develops market-ready molecular genetic diagnostic ...

Steffen Baumgart has overseen his first win as Union Berlin coach as his team ended its 11-game winless run with a 2-1 ...

LEVERKUSEN, Germany (Reuters) -Bayer Leverkusen battled past Mainz 05 with a 1-0 home victory courtesy of a superb Alex ...

Mainz are closing in on signing Montpellier winger Arnaud Nordin (26), reports Le Parisien. An agreement is reportedly close ...

USMNT midfielder Lennard Maloney has joined Mainz from Bundesliga rivals Heidenheim. Maloney, 25, has signed a ...

Mainz Biomed N.V. Regains Compliance with Nasdaq Capital Market Listing Requirements ...

Mainz Biomed NV (NASDAQ:MYNZ) ("Mainz Biomed" or the "Company"), a molecular genetics diagnostic company specializing in the early ...